Related Experiment Video
Updated: Aug 11, 2026
11:02
Isolation and Physiological Analysis of Mouse Cardiomyocytes
Published on: September 7, 2014
Apoptosis in heart: basic mechanisms and implications in cardiovascular diseases
1Cardiovascular Division, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215, USA. pkang@bidmc.harvard.edu
Trends in Molecular Medicine
|May 3, 2003
Summary
Inhibiting apoptosis, programmed cell death, offers a promising therapeutic strategy for heart diseases. Further research is needed to understand its role in heart failure and its connection to cardiac hypertrophy signaling.
Area of Science:
- Cardiology
- Molecular Biology
- Pathophysiology
Background:
- Apoptosis, or programmed cell death, plays a critical role in the pathogenesis of acute and chronic heart diseases.
- Myocardial loss due to apoptosis is a key factor in cardiac disease progression.
- Understanding the molecular mechanisms of cardiac apoptosis is crucial for developing effective treatments.
Purpose of the Study:
- To summarize the current understanding of apoptosis in heart diseases.
- To highlight the therapeutic potential of inhibiting cardiac apoptosis.
- To identify knowledge gaps regarding apoptosis in heart failure and its link to hypertrophic signaling.
Main Methods:
- Review of existing literature on cardiac apoptosis.
- Analysis of molecular mechanisms involved in programmed cell death in the heart.
- Examination of signaling pathways related to cardiac hypertrophy and apoptosis.
Main Results:
- Apoptosis is confirmed as a significant factor in various heart conditions.
- Molecular pathways regulating cardiac apoptosis have been increasingly elucidated.
- The influence of hypertrophic signaling molecules on apoptosis has been characterized.
Conclusions:
- Inhibition of apoptosis presents a promising therapeutic avenue for heart diseases.
- Further investigation is required to fully grasp the significance of apoptosis in heart failure pathogenesis.
- The intricate relationship between cardiac hypertrophic signaling and apoptosis warrants deeper exploration.
Related Concept Videos
01:30Overview of Cell Death
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
01:30Apoptosis
Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
01:31The Intrinsic Apoptotic Pathway
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
01:17Pathophysiology of Heart Failure
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
01:27Heart Failure I: Introduction
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
01:22Cellular Injury V: Apoptosis and Autophagy
Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...